December 28, 2012

A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.

December 28, 2012

The filing seeks to establish a fund to compensate individuals and families affected by a nationwide meningitis outbreak.

December 27, 2012

Diplomat Specialty Pharmacy announced that CEO and co-founder Phil Hagerman has been named one of 13 "Michiganders to Watch" by MLive Media Group, a collaborative network of local and statewide Michigan news outlets.

December 27, 2012

A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Hospital.

December 27, 2012

Walgreens Infusion Services has been selected as a contracted provider of a new injectable medication that helps patients with short bowel syndrome.

December 21, 2012

The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said.

December 21, 2012

The Food and Drug Administration has approved a drug to treat a condition that affects people who have had their intestines partially or completely removed, the agency said Friday.

December 20, 2012

An advocacy group said proposed Food and Drug Administration rules for compounding pharmacies would put the public's health and safety at risk.

December 20, 2012

Retail co-pays for drugs are on the rise across all drug types, according to a new study by the Pharmacy Benefit Management Institute.

December 19, 2012

The changing healthcare environment and the challenges and opportunities of specialty pharmacy were the biggest themes at Acro Pharmaceutical Services' sixth annual Payer and Managed Care Symposium in Philadelphia last Thursday.

December 18, 2012

The Food and Drug Administration has approved two generic versions of a drug to treat HIV, according to agency records.

December 18, 2012

A new product makes gripping such things as eating utensils, pens and toothbrushes easier for people with arthritis.

December 18, 2012

A majority of prescribers would prescribe biosimilar versions of two treatments for rheumatoid arthritis within a year of their approval, according to a new study.

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

December 17, 2012

The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

December 14, 2012

Inc. magazine named Diplomat Specialty Pharmacy as one of the country's top 100 job creators as part of the business magazine's inaugural Hire Power Awards. Diplomat Specialty Pharmacy cracked the list at No. 94 with the addition of 233 new positions over the past three years and came in at No. 5 in the company's home state of Michigan.

But though the company comes in at No. 94 on 'Inc.''s list, measured up against the likes of IT Services juggernaut GoDaddy.com or the rapidly growing fast-food chain Colorado Smashburger, Diplomat Specialty is a bellwether all the same — specialty pharmacy is and will be the catalyst for growth in the retail pharmacy industry.

December 14, 2012

The Food and Drug Administration has approved a new leukemia drug made by Ariad Pharmaceuticals, the agency said.

December 12, 2012

A national group representing state boards of pharmacy has announced its support for efforts to strengthen regulations on compounding pharmacies.

December 12, 2012

Thousands of patients in Los Angeles with serious, chronic diseases could soon find themselves unable to get their drugs from community pharmacies, advocates for the pharmacies said.

December 12, 2012

Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, the companies said.

December 12, 2012

Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.

December 11, 2012

Aetna and Cardinal Health Specialty Solutions on Tuesday announced an evidence-based program designed to improve cancer care in Michigan.

December 10, 2012

Amgen is buying an Iceland-based biotech company for $415 million, the two said Monday.

December 10, 2012

The Food and Drug Administration has approved a new use for a cancer drug made by Johnson & Johnson, the agency said Monday.